Vijay P. Kale

559 total citations
20 papers, 423 citations indexed

About

Vijay P. Kale is a scholar working on Molecular Biology, Cell Biology and Physiology. According to data from OpenAlex, Vijay P. Kale has authored 20 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Cell Biology and 4 papers in Physiology. Recurrent topics in Vijay P. Kale's work include Protein Kinase Regulation and GTPase Signaling (4 papers), Immunotoxicology and immune responses (3 papers) and Microtubule and mitosis dynamics (3 papers). Vijay P. Kale is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (4 papers), Immunotoxicology and immune responses (3 papers) and Microtubule and mitosis dynamics (3 papers). Vijay P. Kale collaborates with scholars based in United States, India and Germany. Vijay P. Kale's co-authors include Shantu Amin, Manoj K. Pandey, Jeremy A. Hengst, Jong K. Yun, Shen‐Shu Sung, Dhimant Desai, Mukul R. Jain, Arun Sharma, William E. Sonntag and Julie A. Farley and has published in prestigious journals such as Cancer Research, Journal of Pharmacology and Experimental Therapeutics and Biochimica et Biophysica Acta (BBA) - Biomembranes.

In The Last Decade

Vijay P. Kale

19 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vijay P. Kale United States 11 215 62 52 51 45 20 423
Xue Sun China 16 325 1.5× 54 0.9× 61 1.2× 52 1.0× 44 1.0× 40 675
Hiroaki Nagai Japan 12 357 1.7× 114 1.8× 48 0.9× 55 1.1× 63 1.4× 29 587
Elżbieta Kania Poland 10 290 1.3× 124 2.0× 34 0.7× 68 1.3× 35 0.8× 14 525
Tiejian Nie China 13 253 1.2× 79 1.3× 24 0.5× 60 1.2× 40 0.9× 18 466
Jingping Fan China 14 276 1.3× 32 0.5× 40 0.8× 31 0.6× 38 0.8× 27 505
Ulf Soppa Germany 8 394 1.8× 33 0.5× 68 1.3× 48 0.9× 25 0.6× 9 626
Mariya Misheva United Kingdom 5 272 1.3× 43 0.7× 58 1.1× 41 0.8× 20 0.4× 7 465
Miao Yi China 10 190 0.9× 92 1.5× 35 0.7× 37 0.7× 17 0.4× 20 382
Jung Kuk Kim South Korea 11 228 1.1× 50 0.8× 33 0.6× 33 0.6× 45 1.0× 20 394
Bitna Kang South Korea 13 218 1.0× 45 0.7× 45 0.9× 20 0.4× 41 0.9× 15 440

Countries citing papers authored by Vijay P. Kale

Since Specialization
Citations

This map shows the geographic impact of Vijay P. Kale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vijay P. Kale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vijay P. Kale more than expected).

Fields of papers citing papers by Vijay P. Kale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vijay P. Kale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vijay P. Kale. The network helps show where Vijay P. Kale may publish in the future.

Co-authorship network of co-authors of Vijay P. Kale

This figure shows the co-authorship network connecting the top 25 collaborators of Vijay P. Kale. A scholar is included among the top collaborators of Vijay P. Kale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vijay P. Kale. Vijay P. Kale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Palazzi, Xavier, Armelle Grevot, Magali Guffroy, et al.. (2024). Points to consider regarding the use and implementation of virtual controls in nonclinical general toxicology studies. Regulatory Toxicology and Pharmacology. 150. 105632–105632. 8 indexed citations
2.
Kale, Vijay P., Jeremy A. Hengst, Arati Sharma, et al.. (2023). Characterization of Anticancer Effects of the Analogs of DJ4, a Novel Selective Inhibitor of ROCK and MRCK Kinases. Pharmaceuticals. 16(8). 1060–1060.
3.
4.
Pham, Elizabeth, Anja Henn, Joachim Wahl, et al.. (2022). Abstract 5202: AMG 794, a Claudin 6-targeted half-life extended (HLE) bispecific T cell engager (BITE®) molecule for non-small cell lung cancer and epithelial ovarian cancer. Cancer Research. 82(12_Supplement). 5202–5202. 4 indexed citations
5.
Kale, Vijay P., et al.. (2021). Evaluation of chronic toxicity of cyclocreatine in beagle dogs after oral gavage administration for up to 23 weeks. Toxicology and Applied Pharmacology. 430. 115680–115680. 3 indexed citations
6.
Kale, Vijay P., et al.. (2020). Evaluation of chronic toxicity of cyclocreatine, a creatine analog, in Sprague Dawley rat after oral gavage administration for up to 26 weeks. Regulatory Toxicology and Pharmacology. 117. 104750–104750. 7 indexed citations
7.
Kale, Vijay P., Milan Patel, Kartick C. Pramanik, et al.. (2020). Old drugs, new uses: Drug repurposing in hematological malignancies. Seminars in Cancer Biology. 68. 242–248. 28 indexed citations
8.
Kale, Vijay P., Seth Gibbs, John Taylor, et al.. (2019). Preclinical toxicity evaluation of JD5037, a peripherally restricted CB1 receptor inverse agonist, in rats and dogs for treatment of nonalcoholic steatohepatitis. Regulatory Toxicology and Pharmacology. 109. 104483–104483. 21 indexed citations
9.
Kale, Vijay P., Shantu Amin, & Manoj K. Pandey. (2015). Targeting ion channels for cancer therapy by repurposing the approved drugs. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1848(10). 2747–2755. 78 indexed citations
10.
Hengst, Jeremy A., Todd E. Fox, Vijay P. Kale, et al.. (2015). The Apoptotic Mechanism of Action of the Sphingosine Kinase 1 Selective Inhibitor SKI-178 in Human Acute Myeloid Leukemia Cell Lines. Journal of Pharmacology and Experimental Therapeutics. 352(3). 494–508. 36 indexed citations
11.
Kale, Vijay P., Jeremy A. Hengst, Dhimant Desai, Shantu Amin, & Jong K. Yun. (2015). The regulatory roles of ROCK and MRCK kinases in the plasticity of cancer cell migration. Cancer Letters. 361(2). 185–196. 38 indexed citations
12.
Kale, Vijay P., Jeremy A. Hengst, Dhimant Desai, et al.. (2014). A novel selective multikinase inhibitor of ROCK and MRCK effectively blocks cancer cell migration and invasion. Cancer Letters. 354(2). 299–310. 26 indexed citations
13.
Pandey, Manoj K., Vijay P. Kale, Chunhua Song, et al.. (2014). Gambogic acid inhibits multiple myeloma mediated osteoclastogenesis through suppression of chemokine receptor CXCR4 signaling pathways. Experimental Hematology. 42(10). 883–896. 35 indexed citations
14.
Goswami, S., et al.. (2013). Evaluation of adverse effects of lisinopril and rosuvastatin on hematological and biochemical analytes in wistar rats. Toxicology International. 20(2). 170–170. 9 indexed citations
15.
Kale, Vijay P., et al.. (2012). Effect of repeated freezing and thawing on 18 clinical chemistry analytes in rat serum.. PubMed. 51(4). 475–8. 19 indexed citations
16.
Bixler, Georgina V., Vijay P. Kale, Jacob M. Serfass, et al.. (2012). Neuroglial Expression of the MHCI Pathway and PirB Receptor Is Upregulated in the Hippocampus with Advanced Aging. Journal of Molecular Neuroscience. 48(1). 111–126. 56 indexed citations
17.
Kale, Vijay P., et al.. (2011). Understanding Effect of Operating Parameters on Thermal Performance of Closed Loop Pulsating Heat Pipe: An Experimental Study. International Journal of Current Engineering and Technology. 1 indexed citations
18.
Kale, Vijay P., et al.. (2009). Effect of fasting duration on clinical pathology results in Wistar rats. Veterinary Clinical Pathology. 38(3). 361–366. 33 indexed citations
19.
Kale, Vijay P., et al.. (2005). Leflunomide: a novel disease modifying anti-rheumatic drug.. PubMed. 50(2). 154–7. 10 indexed citations
20.
Kale, Vijay P., et al.. (2005). Falciparum malaria induced retrobulbar neuritis.. PubMed. 50(2). 150–150. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xue Sun Breakdown of academic impact, for papers by Hiroaki Nagai Breakdown of academic impact, for papers by Elżbieta Kania Breakdown of academic impact, for papers by Tiejian Nie Breakdown of academic impact, for papers by Jingping Fan Breakdown of academic impact, for papers by Ulf Soppa Breakdown of academic impact, for papers by Mariya Misheva Breakdown of academic impact, for papers by Miao Yi Breakdown of academic impact, for papers by Jung Kuk Kim Breakdown of academic impact, for papers by Bitna Kang
Rankless by CCL
2026